Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT

BACKGROUND: The randomized, placebo-controlled COLCOT (Colchicine Cardiovascular Outcomes Trial) has shown the benefits of colchicine 0.5 mg daily to lower the rate of ischemic cardiovascular events in patients with a recent myocardial infarction. Here, we conducted a post hoc pharmacogenomic study...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circ Genom Precis Med
Asıl Yazarlar: Dubé, Marie-Pierre, Legault, Marc-André, Lemaçon, Audrey, Lemieux Perreault, Louis-Philippe, Fouodjio, René, Waters, David D., Kouz, Simon, Pinto, Fausto J., Maggioni, Aldo P., Diaz, Rafael, Berry, Colin, Koenig, Wolfgang, Lopez-Sendon, Jose, Gamra, Habib, Kiwan, Ghassan S., Asselin, Géraldine, Provost, Sylvie, Barhdadi, Amina, Sun, Maxine, Cossette, Mariève, Blondeau, Lucie, Mongrain, Ian, Dubois, Anick, Rhainds, David, Bouabdallaoui, Nadia, Samuel, Michelle, de Denus, Simon, L’Allier, Philippe L., Guertin, Marie-Claude, Roubille, François, Tardif, Jean-Claude
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2021
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284376/
https://ncbi.nlm.nih.gov/pubmed/33560138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.120.003183
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller